100 years of serving patients: our Gödöllő plant, near Budapest celebrates a century of history
May 16, 2024 |
CORPORATE
Sixteen years ago, we took over the legacy of a pioneering vaccines and blood derivatives company in Hungary
Kedrion announces RYPLAZIM® now available in US
May 03, 2024 |
CORPORATE
Distribution resumes of medicine to treat Congenital Plasminogen Deficiency
The President and CEO of PPTA visits the Bolognana plant
Mar 11, 2024 |
CORPORATE
The meeting was a valuable opportunity for Kedrion and PPTA to strengthen our ongoing partnership
Birth 2023: our commitment to fighting Rh disease between present and future
Dec 21, 2023 |
EVENTS
Listen to the podcast
Kedrion reinforces its commitment against Rabies
Dec 07, 2023 |
CORPORATE
Agreement with Kamada to continue to serve patients exposed to the Rabies virus in the US and add potential territories
IPIC2023: Kedrion alongside the Immunodeficiency community
Nov 09, 2023 |
EVENTS
Our support for patients’ associations worldwide with the objective of improving the life of individuals affected by PIDs
KEDPLASMA announces nationwide facility remodeling project
Nov 02, 2023 |
CORPORATE
The initiative aims at enhancing the experience of its donors who stand at the beginning of a bridge between patients and their care
